Aurobindo Pharma surges on receiving USFDA Approval for Sildenafil Injection

07 Apr 2015 Evaluate

Aurobindo Pharma is currently trading at Rs. 1350.00, up by 25.05 points or 1.89% from its previous closing of Rs. 1324.95 on the BSE.

The scrip opened at Rs. 1332.00 and has touched a high and low of Rs. 1363.00 and Rs. 1309.00 respectively. So far 183800 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1363.00 on 07-Apr-2015 and a 52 week low of Rs. 528.00 on 17-Apr-2014.

Last one week high and low of the scrip stood at Rs. 1363.00 and Rs. 1210.00 respectively. The current market cap of the company is Rs. 39471.62 crore.

The promoters holding in the company stood at 54.06% while Institutions and Non-Institutions held 36.20% and 9.73% respectively.

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil Injection, 10mg/12.5mL (0.8mg/mL). This is the 9th ANDA (represented by 7 product classes) to be approved out of Unit IV formulation facility in Hyderabad, India for manufacturing general injectable products and will be marketed and sold by Aurobindo’s wholly owned subsidiary AuroMedics Pharma LLC.

Sildenafil Injection 10mg/12.5mL (0.8mg/mL) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD), Revatio (sildenafil) Injection, 10 mg/12.5 mL (0.8 mg/mL), of Pfizer. Sildenafil Injection is indicated for the treatment of adult patients with pulmonary arterial hypertension who are temporarily unable to take oral therapy, but are otherwise clinically and haemodynamically stable.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up. 

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×